36 State Hospital Groups Ask U.S. Supreme Court to End Part B Drug Payment Cuts for 340B Hospitals

If a federal appeals court's decision stands, a nearly 30 percent cut since 2018 in 340B hospitals’ Medicare Part B drug reimbursement "will devastate 340B hospitals and the communities they serve," 36 hospitals groups told the U.S.Supreme Court.

Thirty-six state and regional hospital associations on Tuesday urged the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that upheld the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital

Read More »

Federal Judge Dismisses Hospitals’ 340B Contract Pharmacy Lawsuit Against HHS

A federal district judge in Oakland, Calif., has dismissed the lawsuit by hospitals against the U.S. Health and Human Services (HHS) Department over HHS’s enforcement of its 340B contract pharmacy requirements for drug companies.

U.S. District Judge Yvonne Gonzalez Rogers

Read More »

DOJ Slams Lilly’s Arguments for Derailing 340B Dispute Resolution

The U.S. Justice Department (DOJ) on Tuesday asked a federal district judge in Indianapolis, in a strongly worded filing, to deny drug manufacturer Eli Lilly’s motion in late January to block the 340B program’s new administrative dispute resolution (ADR) process.

Read More »

AstraZeneca Tells Court HHS’s 340B Enforcement Poses “Imminent Irreparable Harm”

AstraZeneca told a federal judge that federal enforcement of 340B contract pharmacy requirements threatens it with "imminent, irreparable harm.” | Shutterstock

Drug manufacturer AstraZeneca on Friday asked the federal district judge in Delaware handling its 340B contract pharmacy lawsuit against the federal government either to issue a preliminary injunction in its favor or expedite court proceedings “to prevent imminent irreparable harm”

Read More »

In Key Hearing, Federal Judge Expresses Doubt About Court’s Ability To Take Action on Contract Pharmacy Matter

Tuesday's hearing in a lawsuit involving drug manufacturers denials of 340B pricing on contract pharmacy drugs was held in the Ronald V. Dellums Federal Building in Oakland, Calif.

A federal district judge in Oakland, Calif., on Tuesday expressed doubt that she had jurisdiction to require the U.S. Health and Human Services Department (HHS) to make drug manufacturers repay 340B hospitals for drug discounts that the companies have declined

Read More »

Hospitals Ask U.S. Supreme Court to End “Crushing” Medicare Payments Cuts for 340B Drugs

Three national hospital groups and three hospitals yesterday asked the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital outpatient

Read More »

AHA Asks CMS to Rein In UHC’s Specialty Pharmacy Policies

The American Hospital Association says UnitedHealthcare's Specialty pharmacy coverage policies undermine the 340B program's intent. | Shutterstock

The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.

In a Feb.

Read More »

Biden Administration Position in Supreme Court ACA Case Has 340B Implications

340B hospitals’ Medicare Part B payment challenge is not the only Supreme Court case next term that will impact the 340B program.

The Biden administration late yesterday told the U.S. Supreme Court that, due to the change in the presidency, the federal government has changed its main position in the lawsuit over the Affordable Care Act’s (ACA) constitutionality. The government now says

Read More »

Court Hearing Today on Hospitals’ 340B Contract Pharmacy Suit Against HHS

Under normal circumstances, today's hearing would be in this federal district courtroom in Oakland, Calif. It will be held virtually instead due to the COVID-19 pandemic.

A federal district judge in Oakland, Calif., is scheduled to hold a hearing this afternoon on the U.S. Health and Human Services (HHS) Department’s motion to dismiss a lawsuit against it by 340B hospitals over HHS’s enforcement of its 340B

Read More »

Court Freezes Trump’s Rule Banning Pharma Rebates to PBMs

The Biden administration and Pharmaceutical Care Management Association (PCMA), the trade association for pharmaceutical benefit managers (PBMs), have agreed to postpone, from January 1, 2022, to January 1, 2023, the effective date of the Trump administration rule eliminating safe harbor

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer